Skip to main content

Table 5 Hematopoetic parameters before, during and after adjuvant radiotherapy in 46 cases from 43 patients

From: Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer

Hemoglobin

Gram/dl

Before ART1

13.8/1.79/14.0 (mean/± SD/median)

During ART2

13.01/1.37/13.0 (mean/± SD/median)

After ART3

13.34/2.03/13.85 (mean/± SD/median)

Cases with Hemoglobin-decline during ART

3/46 (6.5%)

Leukocytes

Thousand/μl

Before ART1

6.58/2.07/6.30 (mean/± SD/median)

During ART2

4.81/1.53/4.40 (mean/± SD/median)

After ART3

5.92/2.08/5.07 (mean/± SD/median)

Cases with Leukocytes-decline during ART

8/46 (17.4%)

Thrombocytes

Thousand/μl

Before ART1

240.43/74.84/226.50 (mean/± SD/median)

During ART2

204.17/71.84/192.0 (mean/± SD/median)

After ART3

228.26/64.03/231.0 (mean/± SD/median)

Cases with Thrombocytes-decline during ART

2/46 (4.5%)

  1. ART = adjuvant radiotherapy.
  2. 1Mean 2.4 months before start of ART (SD: 2.5 months, median 1.78 months).
  3. 2Mean 0.80 months after start of ART (SD: 0.46 months, median 0.70 months).
  4. 3Mean 2.9 months after end of ART (SD: 3.15 months, median 1.57).